Latest news with #ZAP-X
Business Wire
4 days ago
- Health
- Business Wire
ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X ® Gyroscopic Radiosurgery ® platform — a major milestone reflecting the platform's rapid worldwide adoption. The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses. Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter. 'Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,' said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. 'With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski's case is a prime example of how we can address complex tumors while preserving quality of life.' An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure. 'I'm pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,' said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center. The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission. 'The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,' said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows. 'We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,' said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. 'I'm thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.' For information about Jersey Shore University Medical Center's ZAP-X program, visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at and follow us on LinkedIn. Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy. Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit
Business Wire
4 days ago
- Health
- Business Wire
ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X® Gyroscopic Radiosurgery® Platform
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X® Gyroscopic Radiosurgery® platform — a major milestone reflecting the platform's rapid worldwide adoption. The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses. Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter. 'Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,' said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. 'With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski's case is a prime example of how we can address complex tumors while preserving quality of life.' An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure. 'I'm pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,' said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center. The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission. 'The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,' said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows. 'We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,' said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. 'I'm thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.' For information about Jersey Shore University Medical Center's ZAP-X program, visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at and follow us on LinkedIn. ABOUT HACKENSACK MERIDIAN HEALTH Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy. Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit
Business Wire
16-07-2025
- Business
- Business Wire
AIG Hospitals to Bring Cutting-Edge ZAP-X® Gyroscopic Radiosurgery® to South India
HYDERABAD, India--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that AIG Hospital in Hyderabad, India, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform. Reinforcing its commitment to patient-centric innovation, AIG Hospitals will become the first hospital in South India to offer this revolutionary brain tumor treatment. This advancement will empower AIG Hospitals' neurosurgical team to deliver precision-focused care without the need for traditional open surgery, thereby redefining outcomes for patients with brain tumors and other intracranial conditions. Stereotactic Radiosurgery (SRS), widely accepted as an alternative to conventional brain surgery for many patients, is an incision-free outpatient procedure offering surgical-like precision with no anesthesia, and minimal recovery time. However, access to SRS has remained limited globally due to high infrastructure costs and radiation safety challenges. With ZAP-X, AIG Hospitals addresses these constraints while placing India on the global map of next-generation neurosurgical care. 'At AIG, our unwavering mission has always been to bring the most advanced, evidence-backed, and patient-focused medical technologies to India,' said Dr. D Nageshwar Reddy, Chairman, AIG Hospitals. 'The addition of ZAP-X exemplifies this vision. We believe this technology will be a game-changer for patients across India and neighboring regions who can now access world-class radiosurgery without the burden of travel, hospitalization, or surgical recovery.' Developed by Dr. John R. Adler, former Stanford professor of neurosurgery and radiation oncology, the ZAP-X platform is the world's first vault-free radiosurgery system, enabling installation without the need for costly radiation-shielded rooms. It also eliminates reliance on traditional Cobalt-60 radioactive sources, using a modern linear accelerator to deliver biologically consistent and efficient radiation doses. 'The strategic investment in ZAP-X is a reflection of our long-term vision to serve as a quaternary referral center for complex neurosurgical care, not only for India but for Southeast Asia, the Middle East, and Africa,' said Mr. PVS Raju, Vice-Chairman, AIG Hospitals. 'This platform expands our ability to handle high volumes with greater precision, while preserving patient quality of life through non-invasive care.' Built with a gyroscopic, dual-gimbaled design, ZAP-X offers a large spherical workspace to precisely direct radiation beams from thousands of potential angles and thereby reduce dose concentrations within healthy brain tissue. Along with real-time imaging, ultra-low scatter radiation, and sub-millimeter targeting accuracy, these novel advancements aim to improve outcomes for patients with brain metastases, meningiomas, acoustic neuromas, arteriovenous malformations, and trigeminal neuralgia. At the heart of this development lies AIG's Neurosurgical Program, led by Dr. Subodh Raju, Director & HOD, Neurosurgery, whose team will spearhead the clinical deployment of ZAP-X. 'ZAP-X is not just a technological upgrade, it is a paradigm shift,' said Dr. Subodh Raju. 'It enables us to precisely target even the most complex lesions while sparing healthy brain tissue. Patients walk in, undergo the pain-free session in a day-care setup, and walk out without hospitalization, or post-op recovery. This is the future of brain tumor treatment, and it will be now available in Hyderabad.' He added, 'The ability to offer repeat treatments when needed, patient-friendly immobilization without the rigid head frames of the past, and real-time dose monitoring puts this system at the forefront of radiosurgical safety and patient comfort.' With ZAP-X, AIG Hospitals strengthens its position as a neuroscience leader and becomes part of an elite global network of early adopters of this technology. This move aligns with the hospital's larger vision to bridge the gap between cutting-edge research and clinical practice while ensuring equitable access to life-saving innovations. About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn. About AIG Hospitals AIG Hospitals, Gachibowli is one of India's largest tertiary care, multi-specialty hospitals. With its 1000-bed capacity, 400+ consultant doctors and over 40 medical and surgical specialties, the hospital caters to more than 800,000 patients annually coming from all across India, Southeast Asia, Middle East and Africa. AIG is among only a few private hospitals in the country to have a fully functional Translational Research Facility where active bench to bedside research is undertaken in collaboration with many international and national institutes. Apart from being the highest volume center for Gastroenterology in the world with more than 30,000 therapeutic procedures, AIG centers of excellence include Cardiac Sciences, Neurosciences, Pulmonary Medicine, Oncology, and Renal and Bladder Sciences.
Hans India
11-07-2025
- Health
- Hans India
AIG unveils South India's first ZAP-X radiosurgery platform
AIG Hospitals has become the first healthcare provider in South India to introduce the ZAP-X Gyroscopic Radiosurgery Platform, a cutting-edge, non-invasive technology designed for the precise treatment of brain tumors and other intracranial conditions. The platform is expected to be fully operational by the end of 2025 at the hospital's flagship Gachibowli campus. The ZAP-X system, developed by Dr John R Adler—creator of CyberKnife and a former Stanford neurosurgeon—is the world's first vault-free radiosurgery platform. Unlike traditional systems, it eliminates the need for radioactive cobalt and expensive radiation-shielded rooms, using instead a modern linear accelerator to safely deliver consistent radiation doses. 'This is a major step toward democratizing access to world-class neurosurgical care,' said Dr. D Nageshwar Reddy, Chairman of AIG Hospitals. 'We are proud to bring this revolutionary technology to India, allowing patients to receive cutting-edge treatment without needing to travel abroad.' ZAP-X offers multiple clinical advantages, including a gyroscopic, dual-gimbaled design that enables full 360-degree access to the brain. This results in sub-millimeter targeting accuracy and real-time imaging, minimizing radiation exposure to healthy tissues. It is particularly effective for treating brain metastases, meningiomas, acoustic neuromas, arteriovenous malformations (AVMs), and trigeminal neuralgia. Calling it a 'paradigm shift' in neurosurgery, Dr Subodh Raju, Director and Head of Neurosurgery at AIG, emphasised the patient benefits: 'This technology allows patients to walk in, receive treatment as a daycare procedure, and walk out the same day—pain-free, without hospitalization, and with no recovery time.'
Business Wire
01-07-2025
- Business
- Business Wire
ZAP Surgical Systems and Ibn Sina Medical Center to Bring Groundbreaking Non-Invasive Brain Surgery Platform to Africa
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Ibn Sina Medical Center will become the first hospital in Morocco, and the first in Africa, to introduce the cutting-edge ZAP-X ® Gyroscopic Radiosurgery ® platform. This innovative non-invasive surgical robotics system is poised to transform brain cancer treatment across the region. Located in Casablanca, Ibn Sina Medical Center is a state-of-the-art facility currently under construction. The ZAP-X installation is scheduled to begin the summer of 2025, with the first patient treatments planned for fall of 2025. Stereotactic radiosurgery (SRS) is a completely non-invasive and painless outpatient procedure that has revolutionized the treatment of many primary and metastatic brain tumors, as well as other conditions affecting the brain, head, and neck. Typically completed in a single brief outpatient visit, SRS allows patients to often resume normal activities on the same day as treatment. Dr. Faouzi L' Habeeb, radiation and medical oncologist, managing partner and chairman at Ibn Sina Medical Center, commented, 'The ZAP-X platform signifies the future of brain tumor treatment, allowing us to improve patients' quality of life both throughout and following their treatment.' A primary motivation behind Ibn Sina Medical Center's acquisition of the ZAP-X system is its self-contained, self-shielded design. This unique feature eliminates the requirement for hospitals to build expensive, shielded radiation vaults. 'ZAP Surgical's mission is to make world-class stereotactic radiosurgery accessible to the millions of patients who currently lack access,' commented John R. Adler, MD, Professor Emeritus of Neurosurgery at Stanford University and Founder and CEO of ZAP Surgical Systems. 'By reducing the costs and complexities of traditional SRS delivery, ZAP aims to support providers such as Ibn Sina Medical Center and others around the globe with best-in-class care.' The ZAP-X system is also renowned for its innovative gyroscopic targeting, enabling radiosurgical beams to be delivered from thousands of potential angles. This pioneering approach enhances precision by hyper-focusing radiation to intracranial lesions while also minimizing radiation exposure to healthy brain tissue, thus helping to preserve patient cognitive function. Additionally, ZAP-X is the first and only dedicated cranial radiosurgery platform to eliminate the need for Cobalt-60 radioactive isotopes. Instead, it employs a modern linear accelerator to generate radiation, removing the costs and logistical challenges associated with acquiring, securing, and regularly replacing potentially dangerous radioactive materials. 'The entire ZAP team is honored to work alongside Dr. L' Habeeb and the clinical team at Ibn Sina Medical Center,' said Ahmed Salem, Regional Business Director for ZAP Surgical. 'With the addition of ZAP-X, they continue a proud tradition of bringing the latest and most advanced radiation delivery technologies to Morocco.' The successful introduction of this cutting-edge technology to Morocco was spearheaded by Issam Fadil and Faisal Khalil Jouhari of Promedstore Imaging, the official regional distributor of ZAP-X. For more information about ZAP-X, please visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn.
